Smart Mind Maps in Promoting Safe Administration of High-Alert Medications
HAMs- PICU
The Effectiveness of Smart Mind Maps in Promoting Safe Administration of High-Alert Medications Among Nurses in the Pediatric Intensive Care Unit
1 other identifier
interventional
70
0 countries
N/A
Brief Summary
In PICU setting, drug administration, monitoring, and prescribing errors made up most cases (54%) of MEs . Emphasizes these issues requires a multifaceted approach, including staff training, creation of innovative cognitive frameworks, use of electronic prescribing systems, and the promotion of a safety-awareness within healthcare settings. Recently, mind mapping has been applied in the field of nursing education as an advanced conceptual tool. It uses a technique of combining drawings with words to build memory associations between a topic keyword and image, color, or other link allowing learners to effectively store and extract information
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2025
CompletedStudy Start
First participant enrolled
January 4, 2026
CompletedFirst Posted
Study publicly available on registry
January 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 6, 2026
September 1, 2025
6 months
September 8, 2025
January 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Tool I: A Structured Assessment Questionnaire
It will be developed by the researcher which will consist of two parts: Part 1: Socio-demographic Characteristics and Professional Data of Studied Nurses part 2: Knowledge Assessment Tool on AI and Mind Mapping for Nurses (pre/posttest)
2 weeks
Tool II: Nurses' Knowledge Regarding Safe Use of High-Alert Medications (HAMs)
It will be developed to collect data necessary for evaluating nurses' knowledge related to safe use of high-alert medications. The assessment will encompass key domains such as the definition and classification of HAMs, safety precautions during drug administration (including delivery routes and dosage accuracy), and drug regulation (including proper storage, documentation, and handling procedures).
1 month
Tool III: Observational Checklist for Safe Handling of High Alert Medications
It will be developed by the researcherto objectively assess nurses' practices related to the safe handling of high-alert medications in PICUs according to the international recognized guidelines and evidence-based protocols.
2 month
Study Arms (1)
one group pretest/post test
EXPERIMENTALPICU nurses who directly handled HAM
Interventions
designing a smart mind maps as an advanced conceptual tool to help nurses understand well about HAMs
Eligibility Criteria
You may qualify if:
- Nurses on duty in the PICU (who directly handled HAM) irrespectively to their age, sex, educational level.
You may not qualify if:
- Nurses who do not handle with HAM
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
Central Study Contacts
doaa osman ibrahim doaa ibrahim- assistant lecturer, assistant lecturer
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2025
First Posted
January 6, 2026
Study Start
January 4, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 6, 2026
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share
No individual participant data (IPD) will be shared because the study involves sensitive clinical data from a small population, and sharing may pose confidentiality risks despite de-identification. Access Criteria: Not applicable. IPD will not be shared.